Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes

被引:85
作者
Loisel, S
Le Gall, C
Doucet, L
Ferec, C
Floch, V
机构
[1] CHU, UBO, F-29275 Brest, France
[2] CHU Morvan, Lab Anatomopathol, F-29200 Brest, France
基金
美国国家科学基金会;
关键词
D O I
10.1089/104303401300057405
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Several studies have demonstrated that intravenous administration of DNA complexed with cationic lipid vectors induces the production of large quantities of proinflammatory cytokines. In this study we confirm these observations, using cationic lipid DOTAP and cationic phospholipid compounds. Moreover, we demonstrate that although intravenous administration of lipid-DNA complexes does not induce toxic effects in the lung, high transgene expression in lung correlates with histopathological lesions in liver, this fact being documented by high transaminase levels in serum of treated mice. We examine the contribution of various components of the lipoplexes in this observed liver toxicity, as well as in the increasing level of transaminases, and more particularly the role of nonmethylated CpG sequences of plasmid DNA. We show that blood samples from animals treated either with cationic lipid alone, or with cationic lipid complexed with methylated plasmid DNA, contain low levels of transaminases. The significant decrease in transaminase levels after injection of cationic lipid-methylated pDNA complexes leads us to believe that nonmethylated CpG sequences could play a major role in this hepatoxicity. Similar results were observed when using a vector that did not encode a transgene, demonstrating that the expression of luciferase in lung was not responsible for this liver toxicity. All these observations suggest that significant work should be devoted to understand more clearly the mechanism of cationic lipid-DNA complex toxicity, and to overcome the problems subsequent to administration of nonmethylated CpG sequences of plasmid DNA.
引用
收藏
页码:685 / 696
页数:12
相关论文
共 24 条
[1]   Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis:: a double-blind placebo-controlled trial [J].
Alton, EWFW ;
Stern, M ;
Farley, R ;
Jaffe, A ;
Chadwick, SL ;
Phillips, J ;
Davies, J ;
Smith, SN ;
Browning, J ;
Davies, MG ;
Hodson, ME ;
Durham, SR ;
Li, D ;
Jeffery, PK ;
Scallan, M ;
Balfour, R ;
Eastman, SJ ;
Cheng, SH ;
Smith, AE ;
Meeker, D ;
Geddes, DM .
LANCET, 1999, 353 (9157) :947-954
[2]  
CHIST M, 2000, HUM GENE THER, V11, P415
[3]   LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE [J].
FELGNER, PL ;
GADEK, TR ;
HOLM, M ;
ROMAN, R ;
CHAN, HW ;
WENZ, M ;
NORTHROP, JP ;
RINGOLD, GM ;
DANIELSEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7413-7417
[4]   Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency [J].
Floch, V ;
Delépine, P ;
Guillaume, C ;
Loisel, S ;
Chassé, S ;
Le Bolc'h, G ;
Gobin, E ;
Leroy, JP ;
Férec, C .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1464 (01) :95-103
[5]   Cation substitution in cationic phosphonolipids:: A new concept to improve transfection activity and decrease cellular toxicity [J].
Floch, V ;
Loisel, S ;
Guenin, E ;
Hervé, AC ;
Clément, JC ;
Yaouanc, JJ ;
des Abbayes, H ;
Férec, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (24) :4617-4628
[6]  
Freimark BD, 1998, J IMMUNOL, V160, P4580
[7]   Polyethylenimine-based intravenous delivery of transgenes to mouse lung [J].
Goula, D ;
Benoist, C ;
Mantero, S ;
Merlo, G ;
Levi, G ;
Demeneix, BA .
GENE THERAPY, 1998, 5 (09) :1291-1295
[8]   Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy [J].
Griesenbach, U ;
Chonn, A ;
Cassady, R ;
Hannam, V ;
Ackerley, C ;
Post, M ;
Tanswell, AK ;
Olek, K ;
O'Brodovich, H ;
Tsui, LC .
GENE THERAPY, 1998, 5 (02) :181-188
[9]  
Guénin E, 2000, ANGEW CHEM INT EDIT, V39, P629
[10]   CPG MOTIFS IN BACTERIAL-DNA TRIGGER DIRECT B-CELL ACTIVATION [J].
KRIEG, AM ;
YI, AK ;
MATSON, S ;
WALDSCHMIDT, TJ ;
BISHOP, GA ;
TEASDALE, R ;
KORETZKY, GA ;
KLINMAN, DM .
NATURE, 1995, 374 (6522) :546-549